Hydramine and Restrictive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Restrictive pulmonary disease is reported as a side effect among people who take Hydramine (diphenhydramine hydrochloride), especially for people who are male, 50-59 old, also take Tylenol, and have Idiopathic pulmonary fibrosis.

The phase IV clinical study analyzes which people have Restrictive pulmonary disease when taking Hydramine. It is created by eHealthMe based on reports of 113,450 people who have side effects when taking Hydramine from the FDA, and is updated regularly.

What is Hydramine?

Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.

What is Restrictive pulmonary disease?

Restrictive pulmonary disease (reduction in total lung capacity) is found to be associated with 303 drugs and 362 conditions by eHealthMe. Check the latest studies of Restrictive pulmonary disease.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

113,450 people reported to have side effects when taking Hydramine.
Among them, 21 people (0.02%) have Restrictive pulmonary disease.

Could Hydramine cause Restrictive pulmonary disease?

Among these 21 people:

What is the gender of people who have Restrictive pulmonary disease when taking Hydramine? *

female: 6.25 %
male: 93.75 %

What is the age of people who have Restrictive pulmonary disease when taking Hydramine? *

What are other drugs people take besides Hydramine? *

What are other side effects people have besides Restrictive pulmonary disease? *

Fatigue (feeling of tiredness): 19 people, 90.48%
Weakness: 18 people, 85.71%
High Blood Pressure: 17 people, 80.95%
Pneumonia: 16 people, 76.19%
Oxygen Saturation Decreased: 13 people, 61.90%
Dyspnea (difficult or laboured breathing): 13 people, 61.90%
Blood Pressure Diastolic Increased: 12 people, 57.14%
Cough: 12 people, 57.14%
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue): 12 people, 57.14%
Bacterial Infection: 12 people, 57.14%

What are the existing conditions these people have? *

Idiopathic Pulmonary Fibrosis (chronic lung disease): 12 people, 57.14%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 6 people, 28.57%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 6 people, 28.57%
Nausea (feeling of having an urge to vomit): 2 people, 9.52%
Nausea And Vomiting: 1 person, 4.76%
Fever: 1 person, 4.76%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 4.76%
Cyclic Vomiting Syndrome (prolonged episodes of severe nausea, vomiting): 1 person, 4.76%
Constipation: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Hydramine and have Restrictive pulmonary disease?

- Check whether Restrictive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hydramine:

Hydramine (114,900 reports)

Browse all side effects of Hydramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Restrictive pulmonary disease:

Restrictive pulmonary disease (303 drugs)

Browse all the conditions that are associated with Restrictive pulmonary disease:

Restrictive pulmonary disease (362 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride (the active ingredients of Hydramine) and Hydramine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.